ADTX OTC
Aditxt, Inc.
1W: -32.6%
1M: -56.9%
3M: -29.6%
YTD: -100.0%
1Y: -100.0%
3Y: -100.0%
5Y: -100.0%
$0.00
-0.00 (-8.82%)
Weekly Expected Move ±15.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
89 relationships74
As Filer
counterparties named
15
As Counterparty
mentioned by others
4
Rel. Types
2021-12-03
Earliest Filing
2025-08-27
Latest Filing
target: 41
acquirer: 15
partner: 12
investor: 6
Counterparties (Filed by ADTX)
74 relationshipsCompanies named in ADTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Aditxt, Inc. | ADTX | acquirer | Parent company entering into merger agreement amendments | 2025-08-27 | View |
| Adifem, Inc. | — | target | Merger subsidiary formerly known as Adicure, Inc. | 2025-08-27 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target company in merger agreement | 2025-08-27 | View |
| Evofem Biosciences, Inc. | EVFM | investor | Aditxt purchased a senior subordinated convertible note and warrant from Evofem Biosciences, Inc. | 2025-07-01 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target of merger agreement and recipient of equity investment and notes. | 2025-06-09 | View |
| Adimune, Inc. | — | partner | Company's subsidiary mentioned in the context of a weekly update call. | 2025-06-09 | View |
| Adjuvant Global Health Technology Fund, L.P. | — | investor | Security holder granting call option to purchase Evofem securities | 2025-04-15 | View |
| Adjuvant Global Health Technology fund DE, L.P. | — | investor | Security holder granting call option to purchase Evofem securities | 2025-04-15 | View |
| Evofem Biosciences, Inc. | EVFM | target | Issuer of securities subject to the call option agreement | 2025-04-15 | View |
| Evofem Biosciences, Inc. | EVFM | investor | Aditxt purchased a senior subordinated convertible note and warrant from Evofem. | 2025-04-09 | View |
| Adifem, Inc. | — | partner | Adifem entered into a merger agreement and waiver with Aditxt and Evofem. | 2025-04-09 | View |
| Aditxt, Inc. | ADTX | acquirer | Parent company entering merger agreement and making equity investments | 2025-03-24 | View |
| Adifem, Inc. | — | target | Merger subsidiary (formerly Adicure, Inc.) | 2025-03-24 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target company in merger agreement receiving equity investment | 2025-03-24 | View |
| Adifem, Inc. | — | target | Target company in merger agreement, formerly known as Adicure, Inc. | 2024-11-19 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target company in merger agreement to be merged into Merger Sub | 2024-11-19 | View |
| Evofem Biosciences, Inc. | EVFM | investor | Aditxt, Inc. purchased Series F-1 Convertible Preferred Stock from Evofem Biosciences, Inc. | 2024-10-30 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target of merger agreement and counterparty to securities purchase agreement for preferred stock. | 2024-10-03 | View |
| Evofem Biosciences, Inc. | EVFM | partner | Purchased Series F-1 Convertible Preferred Stock and entered into a Market Development Collaboration Agreement. | 2024-09-23 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target company in merger agreement and recipient of parent equity investments. | 2024-09-06 | View |
| Adifem, Inc. | — | target | Target company in merger agreement, formerly known as Adicure, Inc. | 2024-09-06 | View |
| Adivir, Inc. | — | acquirer | Wholly owned subsidiary of Aditxt, Inc. acquiring Appili Therapeutics, Inc. | 2024-08-21 | View |
| Appili Therapeutics, Inc. | — | target | Canadian corporation being acquired by Adivir, Inc. | 2024-08-21 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target of merger and recipient of Series F-1 Convertible Preferred Stock investment | 2024-08-13 | View |
| Adicure, Inc. | — | target | Former name of Adifem, Inc., the target of the merger | 2024-08-13 | View |
| Adifem, Inc. | — | target | Target of merger and recipient of Series F-1 Convertible Preferred Stock investment | 2024-08-13 | View |
| Adivir, Inc. | — | acquirer | Wholly owned subsidiary of Aditxt, Inc. entering into an arrangement agreement to acquire Appili Therapeutics, Inc. | 2024-07-22 | View |
| Appili Therapeutics, Inc. | — | target | Canadian corporation whose Class A common shares are being acquired by Adivir, Inc. | 2024-07-22 | View |
| Adifem, Inc. | — | target | Wholly owned subsidiary of Aditxt, Inc. (Merger Sub) used to merge into Evofem. | 2024-07-18 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target company in the merger with Aditxt, Inc. and investor in Aditxt, Inc.'s Series F-1 Preferred Stock. | 2024-07-18 | View |
| Lupin, Inc. | — | partner | Counterparty to an Asset Purchase Agreement entered into by Evofem. | 2024-07-18 | View |
| Appili Therapeutics, Inc. | — | target | Canadian corporation being acquired by Adivir, Inc. | 2024-07-08 | View |
| Adivir, Inc. | — | acquirer | Wholly owned subsidiary of Aditxt, Inc. acquiring Appili Therapeutics, Inc. | 2024-07-08 | View |
| Evofem Biosciences, Inc. | EVFM | partner | Target company in the Merger Agreement | 2024-06-21 | View |
| Adicure, Inc. | — | partner | Merger Sub in the Merger Agreement | 2024-06-21 | View |
| Adifem, Inc. | — | target | Wholly owned subsidiary of Aditxt, Inc. and target of the merger agreement. | 2024-05-03 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target company in the merger agreement with Aditxt, Inc. | 2024-05-03 | View |
| Adivir, Inc. | — | acquirer | Wholly owned subsidiary of Aditxt, Inc. acting as the buyer in the acquisition of Appili Therapeutics, Inc. | 2024-04-04 | View |
| Appili Therapeutics, Inc. | — | target | Canadian corporation whose Class A common shares are being acquired by Adivir, Inc. | 2024-04-04 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target company in the merger with Aditxt, Inc.'s subsidiary. | 2024-03-04 | View |
| Adicure, Inc. | — | partner | Wholly owned subsidiary of Aditxt, Inc. involved in the Merger Agreement. | 2024-03-04 | View |
| Adicure, Inc. | — | target | Target company in a merger agreement with Evofem Biosciences, Inc. | 2024-02-02 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target company in a merger agreement with Adicure, Inc. | 2024-02-02 | View |
| Brain Scientific, Inc. | — | target | Target of asset acquisition and subject of bankruptcy assignment | 2024-01-30 | View |
| Philip J. von Kahle | — | target | Seller of patents and affiliated entities | 2024-01-30 | View |
| Adicure, Inc. | — | target | Target of merger agreement | 2024-01-09 | View |
| Pearsanta, Inc. | — | target | Target of asset purchase for early cancer detection platform assets | 2024-01-09 | View |
| MDNA Life Sciences, Inc. | — | target | Target of asset purchase for early cancer detection platform assets | 2024-01-09 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target of merger agreement | 2024-01-09 | View |
| Adicure, Inc. | — | target | Target of a merger with a wholly owned subsidiary of Aditxt, Inc. | 2024-01-02 | View |
| Evofem Biosciences, Inc. | EVFM | target | Target of a merger with a wholly owned subsidiary of Aditxt, Inc. | 2024-01-02 | View |
| Evofem Biosciences, Inc. | EVFM | partner | Target company in the merger agreement with Aditxt | 2023-12-26 | View |
| Adicure, Inc. | — | partner | Merger Sub entity in the merger agreement with Evofem | 2023-12-26 | View |
| Pearsanta, Inc. | — | acquirer | Wholly owned subsidiary of Aditxt, Inc. acquiring assets from MDNA Life Sciences, Inc. | 2023-12-21 | View |
| MDNA Life Sciences, Inc. | — | target | Seller of early cancer detection platform assets to Pearsanta, Inc. | 2023-12-21 | View |
| Evofem Biosciences, Inc. | EVFM | target | Delaware corporation acquired by Aditxt, Inc. via merger with Adicure, Inc. | 2023-12-12 | View |
| Adicure, Inc. | — | target | Wholly owned subsidiary of Aditxt, Inc. used as the merger vehicle to acquire Evofem Biosciences, Inc. | 2023-12-12 | View |
| Cellvera Holdings Ltd. | — | acquirer | Seller of 50% ownership interest in G Response Aid FZE and related assets | 2023-04-25 | View |
| Cellvera Global Holdings LLC | — | acquirer | Seller of 50% ownership interest in G Response Aid FZE and related assets | 2023-04-25 | View |
| Cellvera, Ltd. | — | acquirer | Seller of 50% ownership interest in G Response Aid FZE and related assets | 2023-04-25 | View |
| Cellvera Development LLC | — | acquirer | Seller of 50% ownership interest in G Response Aid FZE and related assets | 2023-04-25 | View |
| AiPharma Group Ltd. | — | acquirer | Seller Owner of 50% ownership interest in G Response Aid FZE and related assets | 2023-04-25 | View |
| Agility, Inc. | — | partner | Holds the remaining 50% ownership interest in G Response Aid FZE | 2023-04-25 | View |
| G Response Aid FZE | — | target | Target company whose 50% ownership interest is being acquired | 2023-04-25 | View |
| The Nasdaq Stock Market LLC | — | investor | Stock exchange where the Company's securities are listed | 2023-04-25 | View |
| AiPharma Group Ltd. | — | target | Target company in a share exchange agreement to be acquired by Aditxt, Inc. | 2022-06-16 | View |
| Cellvera | — | partner | Entity associated with AiPharma Group mentioned in forward-looking statements and proxy solicitation. | 2022-06-16 | View |
| AiPharma Group Ltd. | — | target | Target of share exchange agreement to be acquired by Aditxt, Inc. | 2022-04-05 | View |
| AiPharma Group Ltd. | — | partner | Counterparty to proposed Share Exchange Agreement | 2022-02-14 | View |
| AiPharma Group Ltd. | — | target | Aditxt, Inc. agreed to acquire 100% of AiPharma Group Ltd. in a two-step share exchange transaction. | 2021-12-28 | View |
| AiPharma Global Holdings LLC | — | acquirer | Target of acquisition and lender to Aditxt, Inc. | 2021-12-23 | View |
| AiPharma Global Holdings LLC | — | acquirer | Aditxt agreed to acquire a subsidiary of AiPharma Global Holdings LLC following a restructuring. | 2021-12-20 | View |
| AiPharma Global Holdings LLC | — | target | Aditxt agreed to acquire a subsidiary of AiPharma Global Holdings LLC following a restructuring. | 2021-12-09 | View |
| AiPharma Global Holdings LLC | — | acquirer | Aditxt agreed to acquire a subsidiary of AiPharma Global Holdings LLC following a restructuring. | 2021-12-03 | View |
Mentioned As Counterparty
15 mentionsOther companies that named ADTX in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| EVFM Evofem Biosciences, Inc. | target | Parent company in merger agreement | 2024-11-25 | View |
| EVFM Evofem Biosciences, Inc. | target | Proposed merger target and investor providing Series F-1 convertible preferred stock | 2024-11-06 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company entering into a Support Agreement for the merger of Evofem Biosciences, Inc. | 2024-10-31 | View |
| EVFM Evofem Biosciences, Inc. | investor | Purchaser of Series F-1 Convertible Preferred Stock | 2024-10-28 | View |
| EVFM Evofem Biosciences, Inc. | investor | Buyer purchasing Series F-1 Convertible Preferred Stock | 2024-10-03 | View |
| EVFM Evofem Biosciences, Inc. | investor | Buyer purchasing Series F-1 Convertible Preferred Stock | 2024-09-25 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company entering merger agreement | 2024-09-06 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company entering merger agreement | 2024-08-20 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company acquiring Evofem Biosciences, Inc. in a merger transaction. | 2024-07-18 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company entering into reinstated merger agreement | 2024-05-02 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company entering merger agreement amendment | 2024-03-06 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company in the merger agreement | 2024-01-31 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company in the merger agreement | 2024-01-11 | View |
| EVFM Evofem Biosciences, Inc. | target | Aditxt, Inc. is the parent company acquiring Evofem Biosciences, Inc. in a merger transaction. | 2023-12-27 | View |
| EVFM Evofem Biosciences, Inc. | target | Parent company acquiring Evofem Biosciences, Inc. in a merger transaction. | 2023-12-12 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-23 | Delisting Notice; Exhibits | View | |
| 2026-08-19 | Other Events | View | |
| 2026-07-17 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-06-24 | Delisting Notice; Exhibits | View | |
| 2026-06-23 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-06-10 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-06-09 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-06-05 | Officer/Director Change; Exhibits | View | |
| 2026-06-01 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-29 | Delisting Notice; Exhibits | View | |
| 2026-05-15 | Bylaws Amendment; Regulation FD; Exhibits | View | |
| 2026-05-08 | Delisting Notice; Exhibits | View | |
| 2026-05-01 | Shareholder Vote | View | |
| 2026-04-14 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-04-07 | Exhibits | View | |
| 2026-04-02 | Other Events | View | |
| 2026-03-30 | Other Events; Exhibits | View | |
| 2026-03-13 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creati | Agreement Acquisition | View |
| 2026-03-05 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2026-02-13 | Submission of Matters to a Vote of Security Holders | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR